However, as many tumors contain TP53 missense mutations that produce highly stable mutant proteins with neomorphic gain-of-function properties, we review in a second section how p53 mutants employ EVs in a novel, and often mutation-specific, manner, as oncogenic messengers that reprogram tumor–host communication to promote cancer progression. The gene discussed is TP53; the disease is cancer.